The Food and Drug Administration granted Fast Track Designation for
Galmed Pharmaceuticals Ltd.'s (Nasdaq: GLMD) non-alcoholic steato-hepatitis
treatment aramchol sending the stock price soaring $2.45 to close at $8.93.
Galmed Pharmaceuticals' aramchol granted Fast Track
September 23, 2014 at 17:06 PM EDT
